GSK to plead guilt and pay $3-bn fine
Pharmaceutical giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices, the US Justice Department announced. Read the full US Justice Department statement here














